🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine if Enbrel® or Kineret® will have ...
Status
Completed
Location
Multiple Locations
Start Date
2002-09
Trial ID
NCT00121056
The study is a randomized Phase II, four arm treatment trial. The primary p...
Status
Completed
Location
City of Hope National Medical Center
Start Date
2005-09
Trial ID
NCT00224874
Treatments Being Tested
This is a randomized, double-blind, parallel group, multicenter clinical st...
Status
Unknown
Location
Mochida Investigational site
Start Date
2015-02
Trial ID
NCT02357069
Demonstrate equivalent efficacy of GP2015 and EU-authorized Enbrel in patie...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-02-21
Trial ID
NCT02638259
Treatments Being Tested
The purpose of this study is to determine the preference of RA patients for...
Status
Completed
Location
Multiple Locations
Start Date
2004-10
Trial ID
NCT00094341
Treatments Being Tested
This study aims to demonstrate pharmacokinetic (PK) similarity of biosimila...
Status
Completed
Location
Orchidpharmed PK/PD site
Start Date
2016-12-04
Trial ID
NCT03273088
Treatments Being Tested
The purpose of this study is to assess the feasibility and safety of topica...
Status
Unknown
Location
University Hospital Geneva
Start Date
2016-11
Trial ID
NCT02999776
This is a randomized, double-blind, parallel group, multicentre clinical st...
Status
Completed
Location
Investigational Site
Start Date
2013-06
Trial ID
NCT01895309
Treatments Being Tested
It is known from the COMET-trial that patients who start Enbrel treatment e...
Status
Completed
Location
Multiple Locations
Start Date
2012-02
Trial ID
NCT01623752
Treatments Being Tested
The purpose of this study is to evaluate the safety and effectiveness of et...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2006-01
Trial ID
NCT00293722
Treatments Being Tested